Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Change in Inventory: 2024-2025

Historic Change in Inventory for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Sep 2025 value amounting to $7.2 million.

  • Syndax Pharmaceuticals' Change in Inventory was N/A to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year change of. This contributed to the annual value of $366,000 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Syndax Pharmaceuticals' Change in Inventory stood at $7.2 million, which was down 44.39% from $12.9 million recorded in Q2 2025.
  • Syndax Pharmaceuticals' Change in Inventory's 5-year high stood at $12.9 million during Q2 2025, with a 5-year trough of $366,000 in Q4 2024.
  • Moreover, its 2-year median value for Change in Inventory was $5.7 million (2025), whereas its average is $6.2 million.